87.84MMarket Cap-2.09P/E (TTM)
0.982High0.900Low1.11MVolume0.961Open0.952Pre Close1.03MTurnover1.31%Turnover RatioLossP/E (Static)95.48MShares1.79852wk High0.67P/B77.88MFloat Cap0.73252wk Low--Dividend TTM84.65MShs Float134.960Historical High--Div YieldTTM8.58%Amplitude0.732Historical Low0.928Avg Price1Lot Size
Assertio Stock Forum
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
Friday, 13th December at 8:00 am
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced yesterday results of a clinical trial investigating the utility of Rolvedon® (eflapegrastim-x...
Underated/Valued, overlooked, great buy!!!
This one is killin it....
No comment yet